These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes. Longuemaux S; Deloménie C; Gallou C; Méjean A; Vincent-Viry M; Bouvier R; Droz D; Krishnamoorthy R; Galteau MM; Junien C; Béroud C; Dupret JM Cancer Res; 1999 Jun; 59(12):2903-8. PubMed ID: 10383153 [TBL] [Abstract][Full Text] [Related]
23. Polymorphisms of DNA repair genes are associated with renal cell carcinoma. Hirata H; Hinoda Y; Matsuyama H; Tanaka Y; Okayama N; Suehiro Y; Zhao H; Urakami S; Kawamoto K; Kawakami T; Igawa M; Naito K; Dahiya R Biochem Biophys Res Commun; 2006 Apr; 342(4):1058-62. PubMed ID: 16510122 [TBL] [Abstract][Full Text] [Related]
24. Vascular endothelial growth factor 936 C/T polymorphism is associated with vascular invasion in oral squamous cell carcinoma. Cheng CY; Chang CS; Liu CJ; Kao SY Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Jul; 106(1):79-84. PubMed ID: 18299215 [TBL] [Abstract][Full Text] [Related]
25. Association study of vascular endothelial growth factor and polymorphisms of its gene with ectopic pregnancy. Elito J; Daher S; Fernandes da Silva MO; Marconi NM; Pendeloski KP; Moron AF; Camano L Am J Reprod Immunol; 2010 Feb; 63(2):120-5. PubMed ID: 20015329 [TBL] [Abstract][Full Text] [Related]
26. [Association of ENA-78, IP-10 and VEGF gene polymorphism with idiopathic pulmonary fibrosis]. Liu L; Dai HP; Xiao B; Zhang S; Ban CJ; Xin P Zhonghua Yi Xue Za Zhi; 2009 Oct; 89(38):2690-4. PubMed ID: 20137269 [TBL] [Abstract][Full Text] [Related]
27. The bcl2 -938CC genotype has poor prognosis and lower survival in renal cancer. Hirata H; Hinoda Y; Nakajima K; Kikuno N; Suehiro Y; Tabatabai ZL; Ishii N; Dahiya R J Urol; 2009 Aug; 182(2):721-7. PubMed ID: 19539330 [TBL] [Abstract][Full Text] [Related]
28. Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis. Jin Q; Hemminki K; Enquist K; Lenner P; Grzybowska E; Klaes R; Henriksson R; Chen B; Pamula J; Pekala W; Zientek H; Rogozinska-Szczepka J; Utracka-Hutka B; Hallmans G; Försti A Clin Cancer Res; 2005 May; 11(10):3647-53. PubMed ID: 15897560 [TBL] [Abstract][Full Text] [Related]
29. Analysis of vascular endothelial growth factor gene 936 C/T polymorphism in patients with familial Mediterranean fever. Gunesacar R; Erken E; Ozer HT; Bozkurt B; Dinkci S; Deveci D Int J Immunogenet; 2008 Feb; 35(1):33-6. PubMed ID: 18186798 [TBL] [Abstract][Full Text] [Related]
30. High incidence of CTLA-4 AA (CT60) polymorphism in renal cell cancer. Cozar JM; Romero JM; Aptsiauri N; Vazquez F; Vilchez JR; Tallada M; Garrido F; Ruiz-Cabello F Hum Immunol; 2007 Aug; 68(8):698-704. PubMed ID: 17678726 [TBL] [Abstract][Full Text] [Related]
31. Influence of VEGF polymorphism on progression of autosomal dominant polycystic kidney disease. Reiterová J; Obeidová H; Lenícek M; Stekrová J; Merta M; Maixnerová D; Vítek L; Viklický O; Tesar V Kidney Blood Press Res; 2008; 31(6):398-403. PubMed ID: 19060482 [TBL] [Abstract][Full Text] [Related]
32. The vascular endothelial growth factor (VEGF) +405G>C 5'-untranslated region polymorphism and increased risk of endometriosis in South Indian women: a case control study. Bhanoori M; Arvind Babu K; Pavankumar Reddy NG; Lakshmi Rao K; Zondervan K; Deenadayal M; Kennedy S; Shivaji S Hum Reprod; 2005 Jul; 20(7):1844-9. PubMed ID: 15746194 [TBL] [Abstract][Full Text] [Related]
33. Distribution of the C-460T polymorphism of the vascular endothelial growth factor gene in age-related macular degeneration. Szaflik JP; Błasiak J; Krzyanowska A; Zaraś M; Janik-Papis K; Borucka AI; Woźniak K; Szaflik J Klin Oczna; 2009; 111(4-6):125-7. PubMed ID: 19673440 [TBL] [Abstract][Full Text] [Related]
34. The vascular endothelial growth factor (VEGF) polymorphisms and the risk of endometriosis in northern Iran. Emamifar B; Salehi Z; Mehrafza M; Mashayekhi F Gynecol Endocrinol; 2012 Jun; 28(6):447-50. PubMed ID: 22128802 [TBL] [Abstract][Full Text] [Related]
36. Glutathione S-transferase M1, T1, and P1 polymorphisms as risk factors for renal cell carcinoma: a case-control study. Sweeney C; Farrow DC; Schwartz SM; Eaton DL; Checkoway H; Vaughan TL Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):449-54. PubMed ID: 10794492 [TBL] [Abstract][Full Text] [Related]
37. Genotypes of TNF-alpha, VEGF, hOGG1, GSTM1, and GSTT1: useful determinants for clinical outcome of bladder cancer. Kim EJ; Jeong P; Quan C; Kim J; Bae SC; Yoon SJ; Kang JW; Lee SC; Jun Wee J; Kim WJ Urology; 2005 Jan; 65(1):70-5. PubMed ID: 15667866 [TBL] [Abstract][Full Text] [Related]
38. [Correlation of XPC Ala499Val and Lys939Gln polymorphisms to risks of esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma]. Zhou RM; Li Y; Wang N; Zhang XJ; Dong XJ; Guo W Ai Zheng; 2006 Sep; 25(9):1113-9. PubMed ID: 16965652 [TBL] [Abstract][Full Text] [Related]
39. An interleukin-10 promoter polymorphism may influence tumor development in renal cell carcinoma. Havranek E; Howell WM; Fussell HM; Whelan JA; Whelan MA; Pandha HS J Urol; 2005 Mar; 173(3):709-12. PubMed ID: 15711248 [TBL] [Abstract][Full Text] [Related]
40. Impact of interleukin-18 polymorphisms-607 and -137 on clinical characteristics of renal cell carcinoma patients. Sáenz-López P; Carretero R; Vazquez F; Martin J; Sánchez E; Tallada M; Garrido F; Cózar JM; Ruiz-Cabello F Hum Immunol; 2010 Mar; 71(3):309-13. PubMed ID: 19961892 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]